Exosens Statistics

Total Valuation

Exosens has a market cap or net worth of EUR 1.73 billion. The enterprise value is 1.84 billion.

Market Cap	1.73B
Enterprise Value	1.84B

Important Dates

The last earnings date was Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Exosens has 50.77 million shares outstanding. The number of shares has increased by 37.23% in one year.

Current Share Class	50.77M
Shares Outstanding	50.77M
Shares Change (YoY)	+37.23%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	24.38%
Float	28.43M

Valuation Ratios

The trailing PE ratio is 55.74 and the forward PE ratio is 21.10.

PE Ratio	55.74
Forward PE	21.10
PS Ratio	4.38
PB Ratio	4.18
P/TBV Ratio	20.77
P/FCF Ratio	31.39
P/OCF Ratio	17.93
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.74, with an EV/FCF ratio of 33.41.

EV / Earnings	71.96
EV / Sales	4.66
EV / EBITDA	18.74
EV / EBIT	23.92
EV / FCF	33.41

Financial Position

The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.63.

Current Ratio	2.94
Quick Ratio	2.07
Debt / Equity	0.63
Debt / EBITDA	2.66
Debt / FCF	4.75
Interest Coverage	2.15

Financial Efficiency

Return on equity (ROE) is 9.95% and return on invested capital (ROIC) is 8.03%.

Return on Equity (ROE)	9.95%
Return on Assets (ROA)	6.52%
Return on Invested Capital (ROIC)	8.03%
Return on Capital Employed (ROCE)	10.82%
Revenue Per Employee	301,281
Profits Per Employee	19,519
Employee Count	1,401
Asset Turnover	0.53
Inventory Turnover	1.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	33.02
200-Day Moving Average	23.52
Relative Strength Index (RSI)	50.47
Average Volume (20 Days)	95,372

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Exosens had revenue of EUR 394.08 million and earned 25.53 million in profits. Earnings per share was 0.61.

Revenue	394.08M
Gross Profit	229.34M
Operating Income	76.81M
Pretax Income	41.81M
Net Income	25.53M
EBITDA	94.40M
EBIT	76.81M
Earnings Per Share (EPS)	0.61

Full Income Statement

Balance Sheet

The company has 150.19 million in cash and 261.28 million in debt, giving a net cash position of -111.08 million or -2.19 per share.

Cash & Cash Equivalents	150.19M
Total Debt	261.28M
Net Cash	-111.08M
Net Cash Per Share	-2.19
Equity (Book Value)	412.60M
Book Value Per Share	8.13
Working Capital	207.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 96.25 million and capital expenditures -41.26 million, giving a free cash flow of 55.00 million.

Operating Cash Flow	96.25M
Capital Expenditures	-41.26M
Free Cash Flow	55.00M
FCF Per Share	1.08

Full Cash Flow Statement

Margins

Gross margin is 58.20%, with operating and profit margins of 19.49% and 7.79%.

Gross Margin	58.20%
Operating Margin	19.49%
Pretax Margin	10.61%
Profit Margin	7.79%
EBITDA Margin	23.96%
EBIT Margin	19.49%
FCF Margin	13.96%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.29%.

Dividend Per Share	0.10
Dividend Yield	0.29%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.23%
Shareholder Yield	-36.93%
Earnings Yield	1.48%
FCF Yield	3.19%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exosens has an Altman Z-Score of 2.71. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.71
Piotroski F-Score	n/a